Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Jay Achar James A Seddon Gwenan M Knight Peter J Dodd Hanif Esmail Jennifer Hughes C Finn McQuaid

Eur Respir J

TB Modelling Group, TB Centre, Centre for Mathematical Modelling of Infectious Diseases and AMR Centre, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Published: November 2023

Download full-text PDF	Source
http://dx.doi.org/10.1183/13993003.00969-2023	DOI Listing

Publication Analysis

Top Keywords

guiding pragmatic

pragmatic treatment

treatment choices

choices rifampicin-resistant

rifampicin-resistant tuberculosis

tuberculosis absence

absence second-line

second-line drug

drug susceptibility

susceptibility testing

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!